Filing Details

Accession Number:
0001562180-21-002912
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-22 17:06:52
Reporting Period:
2021-04-22
Accepted Time:
2021-04-22 17:06:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314595 Dennis Podlesak C/O Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-22 13,967 $14.11 43,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase prices ranged from $13.98 to $14.29.